Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose
    Published on 2023-08-16
    2 years ago
  • Finding new and better treatments for psychiatric disorders
    Published on 2023-08-15
    2 years ago
  • A path to novel, effective treatments for schizophrenia
    Published on 2023-08-14
    2 years ago
  • Calcitonin receptor signal: a potential target for opioid use disorder?
    Published on 2023-08-14
    2 years ago
  • Unraveling the cell-type-specific molecular pathways of PTSD: integrating GWAS with brain genomic profiling and in vitro modeling
    Published on 2023-08-14
    2 years ago
  • Towards personalized medicine: subtyping using functional profiles
    Published on 2023-08-14
    2 years ago
  • Postmortem-derived iPSC models in substance use disorders research
    Published on 2023-08-14
    2 years ago
« Previous 1 … 84 85 86 87 88 … 143 Next »
Journal of Psychopharmacology
  • Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action
    Published on 2021-03-20
    5 years ago
  • Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence
    Published on 2021-03-17
    5 years ago
  • Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials
    Published on 2021-03-15
    5 years ago
  • Methylphenidate reduces orienting bias in healthy individuals
    Published on 2021-03-15
    5 years ago
  • Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement
    Published on 2021-03-11
    5 years ago
  • Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania
    Published on 2021-03-11
    5 years ago
  • Associations between lifetime classic psychedelic use and markers of physical health
    Published on 2021-03-10
    5 years ago
« Previous 1 … 84 85 86 87 88 … 134 Next »
European Neuropsychopharmacology
  • Biomarkers of response to rapid-acting antidepressants
    Published on 2021-09-15
    4 years ago
  • Opioid use and misuse in Europe: COVID-19 new challenges?
    Published on 2021-09-14
    4 years ago
  • Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
    Published on 2021-09-10
    4 years ago
  • Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depression
    Published on 2021-09-10
    4 years ago
  • Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials
    Published on 2021-09-04
    4 years ago
  • Well-Being, Resilience and Post-traumatic growth in the Era of Covid-19 Pandemic
    Published on 2021-09-03
    4 years ago
  • Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up
    Published on 2021-09-02
    4 years ago
« Previous 1 … 84 85 86 87 88 … 154 Next »

   Pharma Pub